Table 3 Summary of published reports of tumoral GIT bleeding treated with trans-arterial embolization
Study | Study years | No. | Pathological type | Location | Embolic material | Technical success | Clinical success | 30 days mortality | Overall mortality |
|---|---|---|---|---|---|---|---|---|---|
Lee et al. [20] | 2000–2008 | 23 | Adenocarcinoma | Stomach | Gelatine sponge, NBCA, and microcoils. | 100% | 52% (75% for acute GI bleeding, 43% for tumor with contrast staining and 38% for tumor with –ve angiography | 43% | 100% (Up to 365 days) |
Fidelman [23] | 2005–2008 | 5 | RCC metastases to the GI tract | Stomach (3), duodenum (2), Ileum (1) | Microcoils, Embosphere and PVA particles | 100% | 75% | 0% | 60% |
Tandberg et al. [19] | 2005–2011 | 26 | Adenocarcinoma (11) GIST (4) Pancreatic adenocarcinoma (2) Cholangio-carcinoma (1) GB adenocarcinoma (1) RCC mets to GI (2) Neuroendocrine (1) Lymphoma (1) Melanoma (2) SCC (1) | Esophagus (1), stomach (6), duodenum (9) Jejunum (2), sigmoid colon (2) Rectum (6) | Microcoils and PVA particles | 100% | 68% (91% for acute GI bleeding and 50% for chronic GI bleeding) | NA | NA |
Meehan et al. [21] | 2002–2012 | 10 | Adenocarcinoma | Stomach | Gelatine sponge, NBCA, microcoils, Embosphereand beads | 100% | 40% | 60% | NA |
Koo et al. [25] | 2007–2012 | 20 | GIST | Stomach (5) Duodenum (2) Ileum (3) Jejunum (9) Jejunum and colon (1). | Gelatine sponge, NBCA, and microcoils | 95% | 90% | 10% | 30% |
Zheng et al. [24] | 2001–2015 | 11 | Lymphoma | Stomach | Gelatine sponge, NBCA, and microcoils. | 100% | 27% | 18% | NA |
Park et al. [22] | 2000–2015 | 40 | Adenocarcinoma | Stomach | Gelatine sponge, NBCA,PVA microcoils and particles | 85% | 65% | 25% | 92% (up to 462 days) |
Current study | 2015–2017 | 10 | Adenocarcinoma (7) lymphoma (1) GIST (2) | Stomach (6) Small bowel (3) Colon (1) | Gelatine sponge and PVA particles | 100% | 78.4% | 7.1% | 35.4% |